Correlation Between Cns Pharmaceuticals and Windtree Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Windtree Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Windtree Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and Windtree Therapeutics, you can compare the effects of market volatilities on Cns Pharmaceuticals and Windtree Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Windtree Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Windtree Therapeutics.

Diversification Opportunities for Cns Pharmaceuticals and Windtree Therapeutics

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Cns and Windtree is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Windtree Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Windtree Therapeutics and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Windtree Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Windtree Therapeutics has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Windtree Therapeutics go up and down completely randomly.

Pair Corralation between Cns Pharmaceuticals and Windtree Therapeutics

Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the Windtree Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cns Pharmaceuticals is 1.58 times less risky than Windtree Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The Windtree Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  357.00  in Windtree Therapeutics on August 29, 2024 and sell it today you would lose (296.02) from holding Windtree Therapeutics or give up 82.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Cns Pharmaceuticals  vs.  Windtree Therapeutics

 Performance 
       Timeline  
Cns Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
Windtree Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Windtree Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cns Pharmaceuticals and Windtree Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cns Pharmaceuticals and Windtree Therapeutics

The main advantage of trading using opposite Cns Pharmaceuticals and Windtree Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Windtree Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Windtree Therapeutics will offset losses from the drop in Windtree Therapeutics' long position.
The idea behind Cns Pharmaceuticals and Windtree Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stocks Directory
Find actively traded stocks across global markets